Individuals living with a combination of diabetes and cardiovascular disease are more likely to have a shorter life expectancy, researchers from the University of Cambridge found.
Individuals living with a combination of diabetes and cardiovascular disease are more likely to have a shorter life expectancy, researchers from the University of Cambridge published in a study in JAMA.
Men age 60 years are estimated to have 12 years of reduced life expectancy if they have any 2 of the cardiometabolic conditions, or a combination of diabetes, stroke, or myocardial infarction heart attack; women of the same age who were living with all 3 conditions were expected to live 16 fewer years than those who did not have these conditions.
Men and women who were younger experienced even larger life expectancy reductions than their counterparts. A 40-year-old man with all cardiometabolic conditions had, on average, 23 years of reduced life expectancy and women followed suit, demonstrating an average of 20 years shorter life expectancy.
“Although patients with more than 1 condition constitute only a small proportion of the population at large, in real terms the numbers are not insignificant,” John Danesh, DPhil, professor and head of the Department of Public Health and Primary Care at the University of Cambridge, said in a statement. “Measures aimed at reducing diabetes and heart disease amongst this group could have a dramatic impact on their lives. However, at the same time, we must not lose sight of tackling these serious conditions within the wider population.”
The researchers analyzed more than 135,000 deaths from prolonged follow-ups of more than 1.2 million patients. The team also gathered data from the Emerging Risk Factors Collaboration, which included 700,000 patients between 1960 and 2007.
Previous researchers observed that 10 million adults in the United States and European Union currently live with more than 1 cardiometabolic disease. This new study outlined that 1 in 100 individuals of the population group examined live with 2 or more cardiometabolic diseases.
“Our results highlight the importance of preventing heart disease and stroke amongst patients with diabetes, and likewise averting diabetes amongst heart disease patients,” Dr Danesh said.
Exclusive Telemedicine Use Linked to Less Favorable Glycemic Outcomes for T2D Endocrinology Care
December 6th 2023Adults with type 2 diabetes (T2D) undergoing endocrinology care are more likely to experience less favorable hemoglobin A1c improvements if they only use telemedicine compared with patients using in-person care or a mix of both.
Read More
How Can Employers Leverage the DPP to Improve Diabetes Rates?
February 15th 2022On this episode of Managed Care Cast, Jill Hutt, vice president of member services at the Greater Philadelphia Business Coalition on Health, explains the Coalition’s efforts to reduce diabetes rates through the Diabetes Prevention Program (DPP).
Listen
Study Reveals Factors That Further Increase Colorectal Cancer Risk for Adults With T2D
November 14th 2023The strongest associations between diabetes and colorectal cancer risk were observed in participants with a recent diabetes diagnosis and those who had not undergone recent colonoscopy, underscoring the significance of cancer screening.
Read More
Balancing Care Access and Fragmentation for Better Outcomes in Veterans With Diabetes
April 22nd 2021The authors of a study in the April 2021 issue of The American Journal of Managed Care® discuss the possible reasons behind the link between care fragmentation and hospitalizations in veterans with diabetes, as well as potential opportunities to address disjointed care in the context of the widespread telehealth uptake seen during the COVID-19 pandemic.
Listen